Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses

Electro- and Magnetobiology

Volumn 17, Issue 2, 1998, Pages 299-306

  Serša, Gregor ^a   Beravs, Katarina ^b   Čemažar, Maja ^a   Miklavčič, Damijan ^c   Demsar, Franci ^b  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Electroporation; Fibrosarcoma experimental; Magnetic resonance imaging; Tumor blood volume

Indexed keywords

EID: 0344972285     PISSN: 10619526     EISSN: None     Source Type: Journal    
DOI: 10.3109/15368379809022574     Document Type: Article

References (30)

1. Heywang-Koerbrunner, S.H.: Contrast-enhanced magnetic resonance imaging of the breast, Invest. Radiol. 29, 94-104, 1994.
2. Brasc, R.C.: Rationale and applications for macromolecular Gd-based contrast agents, Magn. Reson. Med. 22, 282-287, 1991.
3. Larsson, H.B.W., Stubgaard, M., Frederiksen, J.L., Jensen, M., Henriksen, O., and Paulson, O.B.: Quantification of blood-brain barrier defect by magnetic resonance iamging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors, Magn. Reson. Med. 16, 117-131, 1990.
4. Schwickert, H.C., Roberts, T.P.L., Muehler, A., Stiskal, M., Demsar, F., and Brasch, R.C.: Angiographic properties of Gd-DTPA-24-cascade-polymer: a new macromolecular contrast agent, Eur. J. Radiol. 20, 144-150, 1995.
5. Schwickert, H.C., Stiskal, M., Roberts, T.P.L., van Dijke, C.F., Mann, J., Muehler, A., Shames, D.M., and Brasch, R.C.: Contrast-enhanced MRI assessment of tumor capillary permeability: the effect of preirradiation on the tumour delivery of chemotherapy, Radiology 198, 893-898, 1996.
6. White, D.L., Wang, S.C., Aicher, K.P., Dupon, J.W., Engelsad, B.L., and Brasch, R.C.: Albumin-(DTPA-Gd)15-20: whole-body clearance, plasma clearance and organ distribution of gadolinium, in book of abstracts: Society of Magnetic Resonance in Medicine (SMRM) 1989, 807, Berkeley, CA.
7. Schmiedel, U., Ogan, M.D., Moseley, M.E., and Brasch, R.C.: Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats, Am. J. Roentgenol. 147, 1263-1270, 1986.
8. Schmiedel, U., Ogan, M.D., Paajanen, H., Marotti, M., Crooks, L.E., Brito, A.C., and Brasch, R.C.: Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies, Radiology 162, 205-210, 1987.
9. Cohen, F.M., Kuwatsura, R., Shames, D.M., Neuder, M., Mann, J.S., Vexler, V., Rosenau, W., and Brasch, R.C.: Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation, Invest. Radiol. 29, 970-977, 1994.
10. Song, C.W.: Effect of local hyperthermia on blood flow and microenvironment, Cancer Res. 44, 4721-4730, 1984.
11. Fingar, V.H., and Henderson, B.W.: Drug and light dose dependence of photodynamic therapy: a study of tumour and normal tissue response, Photochem. Photobiol. 46, 837-841, 1987.
12. Gamarra, F., Spelsberg, F., Kuhnle, G.e.H., and Goetz, A.E.: High-energy shock waves induce blood flow reduction in tumors, Cancer Res. 53, 1590-1595, 1993.
13. Naredi, P.L.J., Lindner, P.G., Holmberg, S.B., Stenram, U., Peterson, A., and Hafström, L.R.: The effects of tumour necrosis factor alpha on the vascular bed and blood flow in an experimental rat hepatoma, Int. J. Cancer 54, 645-649, 1993.
14. Braunschweiger, P.G., Johnson, C.S., Kumar, N., Ord, V., and Furmonski, P.: Antitumor effects of recombinant human interleukin Ia in RIF-1 and PancO2 solid tumours, Cancer Res. 48: 6011-6016, 1988.
15. Chaplin, D.J.: The effect of therapy on tumor vascular function, Int. J. Radiat. Biol. 60, 311-325, 1991.
16. Hill, S.A., Sampson, L.E., and Chaplin, D.J.: Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid, Int. J. Cancer 63, 119-123, 1995.
17. Mir, L.M., Orlowski, S., Belehradek, Jr. J., Teissie, J., Rols, M.P., Sersa, G., Miklavcic, D., Gilbert, R., and Heller, R.: Biomedical application of electric pulses with special emphasis on antitumor electrochemotherapy, Bioelectrochem. Bioenerg. 38, 203-207, 1995.
18. Mir, L.M., Orlowski, S., Belehradek, Jr. J., and Paoletti, C.: Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulse, Eur. J. Cancer 27, 68-72, 1991.
19. Heller, R., Jaroszeski, M., Messina, L.J., Perrot, R., van Voorhis, N., Reintgen, D., and Gilbert, R.: Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy, Bioelectrochem. Bioenerg. 36, 83-87, 1995.
20. Sersa, G., Cemazar, M., Miklavcic, D., and Mir, L.M.: Electrochemotherapy: variable anti-tumor effect on different tumor models, Bioelectrochem. Bioenerg. 35, 23-27, 1994.
21. Serša, G., Cemazar, M., and Miklavcic, D.: Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice, Cancer Res. 55, 3450-3455, 1995.
22. Ogan, M.D., Schmiedl, U., Moseley, M.E., Grodd, W., Paajanen, H., and Brasch, R.C.: Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization, Invest. Radiol. 22, 665-671, 1987.
23. Shames, D., Kuwatsura, R., Vexler, V., Muehler, A., and Brasch, R.: Measurements of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique, Magn. Reson. Med. 29, 616-622, 1993.
24. Kuwatsura, R., Shames, D., Muehler, A., et al.: Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging, Magn. Reson. Med. 30, 76-81, 1993.
25. Larsson, H.B., Stubgaard, M., Frederiksen, J.L., Jensen, M., Henriksen, O., and Paulson, O.B.: Quantification of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patient, Magn. Reson. Med. 16, 117-131, 1990.
26. Demsar, F., Roberts, T.P.L., Schwickert, H.C., Shames, D.M., van Dijke, C.F., Mann, J.S. Saeed, M., and Brasch, R.C.: A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution, Magn. Reson. Med. 37, 236-242, 1997.
27. Domenge, C., Orlowski, S., Luboinski, B., De Baere, T., Schwaab, G., Belehradek, Jr. J., and Mir, L.M.: Antitumor electrochemotherapy. New advances in the clinical protocol, Cancer 77, 956-963, 1996.
28. Heller, R., Jaroszeski, M.J., Glass, L.F., Messina, J.L., Rapaport, D.P., DeConti, R.C., Fenske, N.A., Gilbert, R.A., Mir, L.M., and Reintgen, D.S.: Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy, Cancer 77, 964-971, 1996.
29. Rudolf, Z., Stabuc, B., Cemazar, M., Miklavcic, D., Vodovnik, L., and Sersa, G.: Electrochemotherapy with bleomycin: The first clinical experience in malignant melanoma patients, Radiol. Oncol. 29, 229-235, 1995.
30. Sersa, G., Cemazar, M., and Miklavcic, D.: Potentiation of CDDP antitumor effectiveness by electric pulses, Proc. Am. Assoc. Cancer Res. 38, 260, 1997.